Healthcare Industry News

Air pollution kills over 7 million people around the world each year, says the World Health Organization (WHO). To make matters worse, the level of contamination in the air is rising sharply, especially in emerging economies such as China and India. This factor would be instrumental in driving the global nebulizer market from $765.1 million in 2019 to $1,698.1 million in 2030 at a steady 7.4% CAGR between 2020 and 2030. For instance, the air quality index (AQI) in Delhi in 2019 oscillated between 300 and 1,000, which is considered extremely dangerous. Households, manufacturing units, thermal power plants, and the transport sector are the key sources of air pollution, which are leading to an increase in the deaths attributed to asthma, chronic obstructive pulmonary disease (COPD), and other respiratory issues. This is driving the nebulizer market, as such appliances are used to aerosolize the medication and deliver it directly to the lungs. In today’s times, nebulizer sales are rising r

 Around 17.9 million die as a result of cardiovascular diseases (CVDs) and 9.6 million as a result of cancer, every year, says the World Health Organization (WHO). Moreover, over 250 million suffer from chronic obstructive pulmonary disease (COPD), 235 million have asthma, and 422 million are living with diabetes. A lot of these diseases can be detected early via blood tests, which is the primary reason for the increasing demand for lancets. Therefore, the global lancet market, which had generated $830.3 million revenue in 2019, is projected to experience a 9.5% CAGR between 2020 and 2030 (forecast period). A lancet is a pen-like device, which contains a needle connected to a spring, meant to draw sufficient blood, in a minimally invasive manner. Till 2030, the safety bifurcation is predicted to continue generating higher revenue in the lancet market, as the preference for these devices is high, on account of their better safety profile. Owing to their single-use design, they reduce th

 The United Nations (UN) states that for the first time in history, people aged 65 years or more outnumbered children below 5 years of age in 2018, globally. As per the UN, approximately 16% of the world’s population will be aged over 65 years by 2050 and the number of persons aged 80 years or more will surge from 143 million in 2019 to 426 million in 2050. This age pool is creating a significant requirement for urological and intravenous catheters in homecare settings due to its weak urinary bladder and extensive need for regular monitoring. Additionally, the surging prevalence of chronic diseases, such as autoimmune diseases, including type 1 diabetes, inflammatory bowel disease, and systemic lupus erythematosus; neurological disorders, cancer, and cardiovascular diseases (CVDs), will help the catheter market exhibit a CAGR of 8.8% during 2020–2030. The market revenue stood at $14.3 billion in 2019, and it is projected to reach $36.0 billion by 2030. For example, according to the Int

The process of breast reconstruction has drastically improved over the past 20-30 years. Apart from allowing safer procedures, these advances produce improved rates of recovery and aesthetics. They have aided patients of breast cancer and other survivors to experience regular and natural-looking fallouts that increase their confidence.  Positive breast reconstruction trends comprise: Improved Patient Awareness Liberal legislative changes recently have prioritized the education of survivors of breast cancer survivors on rehabilitative options after a mastectomy. An instance is the Breast Cancer Patient Education Act, which necessitates all hospitals that achieve mastectomies to assume this accountability. Enhanced Implant Placement Techniques Breast reconstruction doesn’t use a one-size-fits-all method. Some patients retort better to tissue transfers artificial implants, or a blend of both. One of the state-of-the-art processes is less painful and endorses faster healing. Recognized as

Flow cytometry is a method that measures and then analyses several physical properties of single particles, often cells. The relative size, granularity, and fluorescence intensity of a particle are among the characteristics that are assessed. An optical-to-electronic coupling device measures these properties by observing how well the cell or particle scatters incoming laser and emits fluorescence. By 2030, it is predicted that the flow cytometry market will be worth $10,065.4 million. How Does Flow Cytometry Function? The first phase in the flow cytometry procedure is planning the sample for analysis. Suspend any cells derived from blood, disintegrated tissues, or cell culture. The addition of antibodies tagged with fluorescent probes, or dyes that stain cellular components, allows the other samples to be spoiled.  Cells must first be frozen and permeabilized for antibodies and dyes to penetrate the cell during intracellular protein analysis. After incubating with the antigens or stain